Preliminary Results from TOPAZ-III, A Phase 3b Study Evaluating the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir +/- Ribavirin in Naive or Experienced Adults in Brazil with HCV Genotype 1 Infection and Advanced Fibrosis/Cirrhosis

Página do item simplificado
dc.citation.issueSuppl 1
dc.citation.volume64
dc.contributor.authorPessoa, Mario G.
dc.contributor.authorMadruga Ramalho, Jose Valdez
dc.contributor.authorAlves, Katia
dc.contributor.authorCohen, Daniel E.
dc.contributor.authorNunes, Estevao Portela
dc.contributor.authorCheinquer, Hugo
dc.contributor.authorBrandao-Mello, Carlos E.
dc.contributor.authorMendes-Correa, Maria Cassia
dc.contributor.authorFerraz, Maria Lucia Cardoso Gomes [UNIFESP]
dc.contributor.authorLari, Sara
dc.contributor.authorLui, Li
dc.contributor.authorTripathi, Rakesh
dc.contributor.authorPilot-Matias, Tami
dc.contributor.authorSchulman, Nancy
dc.contributor.authorMartinelli, Ana L.
dc.coverageHoboken
dc.date.accessioned2020-07-31T12:47:36Z
dc.date.available2020-07-31T12:47:36Z
dc.date.issued2016
dc.description.affiliationUniv Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil
dc.description.affiliationCtr Referencia & Treinamento DST AIDS, Sao Paulo, Brazil
dc.description.affiliationAbbVie Inc, N Chicago, IL USA
dc.description.affiliationNatl Inst Infect Dis FIOCRUZ, Rio De Janeiro, Brazil
dc.description.affiliationUniv Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Gastroenterol & Hepatol Unit, Porto Alegre, RS, Brazil
dc.description.affiliationUniv Fed Estado Rio de Janeiro UNIRIO, Coll Med & Surg, Dept Internal Med, Rio De Janeiro, Brazil
dc.description.affiliationUniv Sao Paulo, Sch Med, Dept Infect Dis, Sao Paulo, Brazil
dc.description.affiliationUniv Fed Sao Paulo, Escola Paulista Med, Dept Gastroenterol, Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Ribeirao Preto Sch Med, Dept Med, Div Gastroenterol, Sao Paulo, Brazil
dc.description.affiliationUnifespDepartment of Gastroenterology, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent949A-950A
dc.identifierhttps://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.28800
dc.identifier.citationHepatology. Hoboken, v. 64, n. S1, p. 949A-950A, 2016.
dc.identifier.issn0270-9139
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/56922
dc.identifier.wosWOS:000385493804279
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofHepatology
dc.relation.ispartof67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titlePreliminary Results from TOPAZ-III, A Phase 3b Study Evaluating the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir +/- Ribavirin in Naive or Experienced Adults in Brazil with HCV Genotype 1 Infection and Advanced Fibrosis/Cirrhosisen
dc.typeinfo:eu-repo/semantics/conferenceObject
Arquivos
Coleções
EPM - Outras produções